Wolverine Trading, LLC Cure Vac N.V. Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$7.48 - $15.24 $144,364 - $294,132	19,300 New	19,300 $155,000
Q2 2022 Aug 15, 2022	SELL	$13.18 - $19.41 $202,972 - $298,914	-15,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $226,842 - $542,850	15,400 New	15,400 $297,000
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $1.11 Million - $1.59 Million	-33,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$49.26 - $74.5 $1.63 Million - $2.46 Million	33,000 New	33,000 $1.81 Million

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $716M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.